GW Pharma's Cannabinoid Medicine Epidyolex Among CHMP Hopefuls

 
• By Vibha Sharma and Maureen Kenny

Seven new medicines, including GW Pharma's orphan cannabidiol product, Epidyolex, are due for an opinion from the European Medicines Agency this week on whether they should be recommended for pan-EU approval.

Leaf_Pills
Decision Time On EU-Wide Approval Of First Plant-Derived Cannabinoid • Source: Shutterstock

More from Europe

More from Geography